GlobeNewswire Medical EquipmentCodex · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 04:05:00·⟳ 抓取 04:06:00·⚡ 决策 08-28 13:32:02 +9h26m·60.3 天前
Resmed宣布管理层将参加摩根士丹利全球医疗会议
这是常规投行会议出席与 webcast 通知，没有披露会改变基本面或市场预期的新增信息；不构成方向性交易催化。
📄 原文GlobeNewswire Medical Equipment↗ 原文
Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and ch…
不做 Resmed（RMD.US）
仅为常规投行会议参会公告，无订单、指引、产品批准或资本动作等新增可交易事实。
不做 Resmed（RMD.AU）
同一主体跨市场证券没有独立催化，当前公告不足以形成交易边界。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Resmed只公告CEO和CFO将参加Morgan Stanley全球医疗会议，正文没有业绩、指引、订单、产品、监管或资本动作。该信息最多提示未来可能有管理层交流窗口，当前不形成可量化增量或明确方向，因此不做。
🔎 新鲜度:最早出现 2026-08-27 · 扩散 low · price-in 风险 low ↗
主要风险
- 若会议当天披露新的经营指引、产品进展或需求数据，应作为新事件重新评估。
先例如何影响了这次决策
对本次决策的影响:先例不足不影响结论，核心原因是当前事实层没有交易催化。
方向:普通投行会议参会公告通常不提供方向性基本面增量。
涨幅量级:未形成可用于校准涨跌幅的同类重大事件样本，因为本事件没有可定价业务变化。
形态:不适用；事件本身是日程通知而非催化落地。
原文全文
展开原文 · 1,447 字
SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 24th Annual Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 15, 2026. Resmed’s webcast presentation will begin at approximately 10:00 a.m. (Eastern Time).
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting
https://investor.resmed.com
. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
For investors
For media
+1 858.221.3304
+1 619.510.1281
investorrelations@resmed.com
news@resmed.com
More information about this event, including access to the live, audio-only webcast, may be accessed by visiting
https://investor.resmed.com
. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible for the following ninety (90) days.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
For investors
For media
+1 858.221.3304
+1 619.510.1281
investorrelations@resmed.com
news@resmed.com
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。